BHR Biosynex MoREM® gives real-life evidence - how a pharmacy-led national diabetes screening service would save NHS £50m each year
BHR Biosynex is pleased to have worked with the Company Chemists’ Association (CCA) to produce a report that demonstrates how a community pharmacy diabetes screening service would save the NHS £50m in recurring costs each year.
